I don't disagree with anything you said, maybe I make the mistake of not valuing growth companies by revenue and its growth rather than profit and its growth. Definitely worth sticking around but if there's a hiccup, there's potential to feel ill. My wife owns them,not me, and we will trade them in an effort to bring down average cost.The major thing that worries about A2M is the claimed health benefit of the A2 protein not being all it's cracked up to be.
how can we sack the CEO?, page-26
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.36 |
Change
-0.060(0.93%) |
Mkt cap ! $4.604B | |||
| Open | High | Low | Value | Volume |
| $6.33 | $6.40 | $6.28 | $13.73M | 2.165M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7023 | $6.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.36 | 11699 | 2 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| A2M (ASX) Chart |